Login / Signup

MEK inhibitors enhance therapeutic response towards ATRA in NF1 associated malignant peripheral nerve sheath tumors (MPNST) in-vitro.

Susan Fischer-HuchzermeyerAnna DombrowskiGordon WilkeVerena StahnAnna StreubelVictor Felix MautnerAnja Harder
Published in: PloS one (2017)
We observed therapeutic effects in two of three MPNST cell lines pronounced by combination therapy. These data point to a potentially successful treatment of MPNST by combined application of ATRA and MEK inhibitors such as U0126 or PD0325901.
Keyphrases